Skip to main content

An astonishing 90% of clinical trials fail, often due to flawed study design, poor clinical efficacy, or persistent recruitment challenges.1 In a landscape where every decision matters, success depends on a clear, data-driven strategy, and clinical laboratory data is a critical component. As the definitive source for confirming a disease, it provides the objective information needed to truly understand a patient population.

Maximize trial success with data-driven precision

At Quest Diagnostics, we translate the power of lab data into a decisive advantage for pharmaceutical companies and CROs. Our insights help assess patient availability and validate protocol design from the start. We identify and locate the patients most likely to be eligible for a trial, enabling the development of effective site strategies and precise patient recruitment. By leveraging a foundation of lab data, clinical trial teams can make more informed decisions to mitigate risks and help improve the chances of a successful outcome.

Why choose Quest and our lab data?

From routine diagnostics to advanced genetic testing, Quest’s comprehensive capabilities provide the critical data and vast patient reach that pharmaceutical and CRO teams need—empowering them to make more informed decisions and recruit effectively, driving success for clinical trials across a wide range of therapeutic areas.



Resources

Let’s discuss your next project

Contact our pharma solutions experts to design a custom program to accommodate the needs of your study.

 

Please remember that email, including this web form, is not a secure method of communication. Do not submit personal information, including user names and passwords, social security numbers, or personal health information through this form.

899

* indicates required

Reference

  1. Sun D, Gao W, Hu H, et al. Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B. 2022;12(7):3049-3062. doi:10.1016/j.apsb.2022.02.002